LienTeh.net > Ads > LuciNfig 100 (Infigratinib)

LuciNfig 100 (Infigratinib)

Inquire / Price

Model Number：

RL362025060901
Brand Name：

LuciNfig 100
Origin：

Generic drug，Laos
Small Orders：

Small batches also available
Tags：

Bile duct cancer

Inquire Now Link

Poster

Details
Description

Packaging Size

21c/bottle
Strength

100mg
Compositon

Infigratinib
Treatment

Cholangiocarcinoma (bile duct cancer)
Form

Capsule
Brand

LuciNfig 100
Quantity Unit

100mg*21c/box
Manufacturer

Lucius Pharmaceuticals (Lao) Co.,Ltd

About Infigratinib

Infigratinib is a fibroblast growth factor receptor (FGFR) kinase inhibitor used in the treatment of certain types of cholangiocarcinoma (bile duct cancer) and also under investigation for achondroplasia.

Clinical Studies

The efficacy of Infigratinib (Brand name: Truseltiq) was based on a single-arm Phase 2 study which included 108 patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement. Ninety-nine percent of patients had metastatic (Stage IV) disease at the time of study entry.

These 108 adult patients with advanced/metastatic CCA received infigratinib 125 mg orally for 21 days of each 28-day cycle until unacceptable toxicity or disease progression. All patients received prophylaxis with the oral phosphate binder sevelamer. Truseltiq achieved a 23% objective response rate (ORR) and a median duration of response (DOR) of 5.0 months.